Inovio Pharmaceuticals Stock Is 16% Down In The Last 5 Sessions
Shares of biotechnology company Inovio Pharmaceuticals (NASDAQ: INO) have recently been on a sharp decline. Over the course of five consecutive sessions, the company’s stock plummeted by more than 16%, dropping to sh.42. This drop contributed significantly to NATDAQ’s overall decrease of 1.12%. As of now, Inovio Pharmaceuticals’ shares are trading at prices 84.93% lower…